Supplemental Methods
Two-hundred ten did not meet study eligibility criteria because: they absconded (n = 1), were over the age of 55 (n = 1), anticipated a release or transfer from the facility in less time than would allow for the completion of the protocol (n = 23), were on antipsychotic medication (n = 13), had a family history of psychosis (n = 9), had scheduling conflicts (n = 2), were MRI incompatible (n = 42), did not meet diagnostic criteria for cocaine, heroin, or methamphetamine dependence, or had abstained from substance use for longer than three months prior to incarceration (n = 38), opted not to participate following the consent (n = 13), were diagnosed with psychosis (n = 13), had less than a sixth-grade reading level (n = 23), sought other drug treatment (n = 4), were clinically unstable (i.e., report current or recent suicidal ideation) (n = 7), or had a history of significant traumatic brain injury (n = 5). Exclusion data were unavailable for n = 16 participants. Of the participants completing informed consent and screening for the study, 225 (98 males, 127 females) were assigned to one of three therapy cells using a pseudorandom process. A total of 151 participants (59 males, 93 females) completed the entire therapy protocol (nine or more sessions).
Procedures and Ethical Considerations
Initial contact was made with potential study participants through announcements by research staff at the correctional facilities. Meetings were scheduled with interested participants and informed consent was obtained. Participants were informed of their right to discontinue participation at any point and that their participation was in no way associated with their status at the facility, their parole status, and there were no direct institutional benefits. Participants were paid at the rate of the hourly wage at the facility. All procedures were approved by the Human Research Review Committee at the research institution and correctional facilities where the study was conducted.
Assessment Measures
Depressive symptomatology. Depressive symptomatology was assessed using the Beck Depression Inventory-II (BDI-II) (1), a 21-item self-report measure that assesses the severity of depressive symptoms. Depressive symptom measures were unavailable for five participants. The Cronbach's alpha for the BDI-II in this sample was .90.
Anxiety symptomatology. Anxiety symptomatology was assessed using the State-Trait Anxiety Inventory (STAI) (2), a 40-item measure that assesses the intensity of anxiety symptoms and distinguishes between state anxiety and trait anxiety. Anxiety symptoms were unavailable for eighteen participants. The Cronbach's alpha for the STAI in this sample was .72.
Psychopathy. Psychopathy was assessed using the PCL-R (3, 4), comprising two factors;
Factor 1 assessing callous interpersonal and affective traits, and Factor 2 assessing impulsive lifestyle and antisocial behavior. In the current study, Factor 2 was used as an index of impulsivity. Factor 1 and 2 scores were unavailable for 31 participants. The Cronbach's alpha for the PCL-R in this sample was .77.
Motivation for change.
Motivation for change was assessed using the University of Rhode Island Change Assessment (URICA (5)), a continuous measure of four stages of how a person may feel about making changes before they acknowledge they have a problem (precontemplation), after they acknowledge they have a problem (contemplation), once they take steps toward treatment (action), and maintaining the change (maintenance). URICA scores were unavailable for 15 participants. The Cronbach's alpha for the URICA in this sample was .80. Estimated IQ. IQ was estimated using the Vocabulary and Matrix Reasoning subtests of the Wechsler Adult Intelligence Scale (6) (mean = 96.07, SD = 11.27). IQ scores were unavailable for four participants.
Years of Substance Use. Years of regular substance use were measured using a modified version of the Addiction Severity Index (ASI-X (7)) by calculating the cumulative years of regular use (i.e., three or more times per week for a minimum of one month) for all substances (alcohol, heroin, cocaine, methamphetamine, cannabis, hallucinogens, and inhalants) combined.
Total scores were then divided by participant's age to control for opportunity to use. ASI scores were unavailable for 10 participants. The Cronbach's alpha for the ASI in this sample was .77.
Experimental Go/NoGo Task
Participants then performed a difficult, previously published Go/NoGo paradigm (8) containing two experimental runs, each comprising 245 visual stimuli, presented to participants using the computer-controlled visual presentation software package, Presentation. Each stimulus appeared for 250 ms in white text within a continuously displayed rectangular fixation box.
Participants were instructed to respond as "quickly and accurately as possible" with their right index finger every time the target ("Go") stimulus (a white "X") appeared, and to withhold a response when the distracter "No/Go" stimuli (a white "K") appeared. Targets appeared with higher frequency (84%, 412 trials with 206 for each run) than distractors (16%, 78 trials with 39 for each run) to establish a strong stimulus-response mapping on "Go" trials. Two K's were never presented sequentially. The stimuli were approximately 3 x 5 visual degrees, and were presented for 250 ms on a black background. The interstimulus interval was pseudo-randomly jittered (1-3 s stimulus-onset asynchrony (SOA; 9); averaging 1.5 s). Prior to recording, each participant performed a block of 10 practice trials to ensure that the instructions were clearly understood. The SOA between Go stimuli varied to the constraint that three Go stimuli were presented within each consecutive 6 s period. The NoGo stimuli were interspersed among the Go stimuli in a pseudorandom manner subject to two constraints: the minimum SOA between a Go and NoGo stimulus was 1000 ms; the SOA between successive NoGo stimuli was in the range eight to 14 s.
Analysis of Functional Magnetic Resonance Imaging Data
A mean functional image volume was constructed for each run from the realigned image volumes. The mean EPI image from each run was normalized to the EPI template. The spatial transformation into standard MNI space was determined using a tailored algorithm with both linear and nonlinear components (10) . The normalization parameters determined for the mean functional volume were then applied to the corresponding functional image volumes for each participant. The normalized functional images were smoothed with a 6 mm full width at halfmaximum (FWHM) Gaussian filter. Event-related responses were modeled using a synthetic hemodynamic response function composed of two gamma functions. The first gamma function modeled the hemodynamic response using a peak latency of 6 s. A term proportional to the derivative of this gamma function was included to allow for small variations in peak latency. The second gamma function and associated derivative was used to model the small "overshoot" of the hemodynamic response on recovery. A latency variation amplitude-correction method was used to provide a more accurate estimate of hemodynamic response for each condition that controlled for differences between slices in timing and variation across regions in the latency of the hemodynamic response (11) . High-pass (cutoff period 116 s) and low-pass (cutoff period 0.23 s) filters were applied to remove any low-and high-frequency confounds, respectively.
Condition-specific derivative terms (11) were extracted for analysis. SPM5 using MATLAB 2014a was used for these analyses.
The primary purpose of this study was to use functional network connectivity (FNC) features for classification of substance abuse treatment outcomes. Functional connectivity (FC) is defined as the correlation (or other kinds of statistical dependency) among spatially remote brain regions (12) . FC analysis documents interactions among brain regions either during tasks or during rest. Two widely used FC approaches are: (a) seed-based analysis (13) (14) (15) (16) (17) (18) and (b) spatial Independent Component Analysis (ICA) (19) (20) (21) (22) (23) . ICA is a data-driven multivariate analysis method that identifies distinct groups of brain regions with the same temporal pattern of hemodynamic signal change. In the seed-based approach, individual seed voxels from predefined brain regions of interest (ROI) are chosen and the cross correlation of other voxels' time courses (TCs) with the selected seeds then computed, to derive a correlation map. This map is then thresholded to identify voxels with significant FC with the seed voxels.
An alternative approach is based on ICA, a blind source separation method can recover a set of signals from their linear mixtures. This method has yielded fruitful results with fMRI data (24, 25) . ICA estimates maximally independent components using independence measures based on higher-order statistics. Compared to general linear model approaches, ICA requires no specific temporal model (task-based design matrix), making it ideal for analyzing resting-state data (26) . Depending on the data matrix formation, one can perform either temporal (tICA) or spatial ICA (sICA) on fMRI data with sICA most commonly used (19, 20, 27) . sICA decomposes fMRI data into a set of maximally spatially independent maps and their corresponding time-courses. Each thresholded sICA map may consist of several remote brain regions forming a brain functional network. sICA generates consistent spatial maps while modeling complex fMRI data collected during a task or in a resting-state (28) although the task can result in a subtle modulation of the spatial patterns (29) . The dynamics of the BOLD signal within a single component is described by that component's TC. Regions contributing significantly within a given component are strongly functionally connected to each other.
Group ICA was performed on the preprocessed fMRI time-series data (20) . These methods were implemented in the MATLAB toolbox for ICA of fMRI (GIFT) and have been detailed previously (20, 25) . A two-stage PCA data reduction step was implemented, at the single subject level 150 PCs were extracted, followed by a group PCA step using 75 components, lower than the first step (30) . The number of ICA components was selected in light of evidence that a high number (70-100) of independent components consistently and stably estimate data (31) (32) (33) (34) . The data reduction was followed by a group sICA, performed on the participants' aggregate data, resulting in the final estimation of our ICs. The algorithm used in this process was the infomax algorithm, which attempts to minimize the mutual information of network outputs (35) . This was followed by a back reconstruction of single-subject time courses and spatial maps from the raw data using the group solution to accurately depict the participantto-participant variability that existed in the data (30) . The resulting single-subject time-course amplitudes were then intensity prenormalized (20) . These spatial maps and TCs were then regressed against the same design matrix used in the SPM analysis. Spatial maps were reconstructed and converted to Z-values for each participant. Partial correlations were used to identify 34 non-artifactual components (Figures S1-S5) that were task related (Table S2) . Nonartifactual components are expected to have peak activation in the gray matter and have low spatial overlap with known ventricles, vascular, motion, and susceptibility artifacts.
The FNC (36) among ICA TCs across the entire task were computed using Pearson correlation coefficients. These coefficients were used in support vector machine (SVM) models predicting which individuals would or would not complete treatment. Reducing dimensionality of the FNC features used in the models was crucial considering the current dataset would be considered small compared to the number of features in the context of machine learning. We used double input symmetric relevance (DISR) (37) feature selection method. DISR is a fast filtering method designed to select a feature set that exhibits maximal mutual information with class labels while minimizing the mutual information among the selected features. This method reduced the feature set for each classification run from 561 to 50 for each participant during the cross-validation step. Frequency of selection for each variable was tracked to assess the relative usefulness of each feature in the prediction models.
The accuracy of these SVM models was confirmed with permutation tests. These tests were calculated by randomizing the labels (i.e., group membership as completed treatment or discontinued treatment prematurely) 1000 times and calculating classification measures within each iteration. When randomizing the labels, the ratio of classes constant was held constant. By calculating the proportion of times (of the 1000 iterations) where the measures were greater than our original classification measures, p-values reflecting the stability of our classification models were calculated. Note. All participants (n=139) either successfully completed or discontinued a cognitive behavioral substance abuse treatment program. Individuals in the completed group (n=107) include adult incarcerated offenders who successfully completed nine weeks of a cognitive behavioral substance abuse treatment program. Individuals in the discontinued group (n=32) include adult incarcerated offenders who discontinued treatment prior to nine weeks of a cognitive behavioral substance abuse treatment program. th of the data are set aside for testing, 1/5 th for validation and 3/5 th for training. This model is similar to SVM models previously published from this group (40-45) with further discussion in Steele et al (40) .
